Ra’anana, Israel, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a biotechnology company focusing on the development of intranasal products, today ...
(RTTNews) - Polyrizon Ltd. (PLRZ), a biotechnology company developing intranasal products, reported encouraging preclinical findings showing that its proprietary Trap and Target naloxone hydrogel ...
Polyrizon (PLRZ) announced new preclinical data showing its proprietary naloxone hydrogel adheres to nasal tissue longer than an approved and marketed intranasal naloxone spray product. Using an ...
Looking to improve drug product effectiveness and differentiate? Mucoadhesion – the ability of a formulation to adhere to a mucous membrane – is an attractive option for those keen to ensure their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results